http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4666836-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
filingDate 1982-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_621bf7b3a8001d7c0d5f5f4cac9b0e74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7cef7a2f8dd47b431931e7db3f851dd
publicationDate 1987-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4666836-A
titleOfInvention Novel cloning vehicles for polypeptide expression in microbial hosts
abstract Methods and compositions are provided for expression of polypeptides in transformed bacterial hosts. A novel class of plasmid cloning vehicles includes a DNA sequence coding for the desired polypeptide linked in reading phase with one or more functional fragments derived from an outer membrane protein gene of a gram-negative bacterium, and also linked with an additional promoter sequence in certain cases. The methods utilize such plasmids to introduce genetic capability into microorganisms for the production of proteins, such as medically or commercially useful hormones, enzymes, immunogenic proteins, or intermediates therefor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5795776-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0109350-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4914027-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003190706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6025325-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5945304-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160623-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4863855-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007128696-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0109350-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7501262-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006216307-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008233154-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003232055-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007122421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7183077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008226667-A1
priorityDate 1981-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0001929-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4237224-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4336336-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244

Total number of triples: 38.